ÂÜÀòÂÒÂ×

Amir Kalali, MD, is a highly experienced professional in the biopharma and technology sectors, serving as a Board Member and Executive Advisor for multiple companies since July 2017. As the Co-Chair and Founder of the Decentralized Trials & Research Alliance since January 2020 and the Founder, Chief Curator, and Chairman of CNS Summit since November 2010, Amir has played pivotal roles in advancing clinical research. Additionally, Amir is a member of the Supervisory Board at atai Life Sciences and holds positions on the Board of Directors at Arbor Scientia and the Executive Committees of both the International Society for CNS Drug Development and ISCTM. Other roles include Strategic Advisor at Holmusk and Advisor at Joyance Partners. Amir has also served as the Editor in Chief for Innovation in Clinical Neuroscience since May 2006. Education includes an MD in Medicine from UCL, where studies were completed from 1983 to 1988.